FEMSA Stock Declines 20.8% YTD: Is a Recovery on the Horizon?

About this update from Fomento Economico Mexicano Sab De Cv Units Cons. Of 5 Shsb

Fomento Economico Mexicano S.A.B. de C.V. FMX alias FEMSA shares have witnessed a pullback from the beginning of 2024, with the stock declining as much as 20.8% in the year-to-date period. This pullback in share price relates to the challenges in the Health division that have impacted its performance in recent quarters.FEMSA’s Health division is in a weak spot due to its operations in diverse and often challenging macroeconomic and commercial environments. The Health division is facing complex, competitive, and regulatory issues in several markets, particularly Mexico. This led to disappointing top-line results and soft operating income for the segment in second-quarter 2024.The segment’s revenues in the second quarter were pressured by a persistent negative competitive landscape in Mexico and tough macroeconomic conditions in Ecuador, partially offset by growth in Chile and Colombia. These disappointing revenue trends also led to weaker operating results, with operating income down 14.8% year over year and operating margins contracting by 70 basis points to 4.1%.Despite these challenges, the company is focused on turning around the Health division by quickly adapting country-specific strategies to counter and reverse these negative trends. However, while these efforts are underway, the timing for the near-term recovery of the segment remains uncertain.In the year-to-date period, FEMSA’s shares have lagged the broader industry’s growth of 13.1% and the Consumer Staples sector’s gain of 10.9%. The stock also underperformed the S&P 500 indices 18.1% return for the period.FEMSA's One-Year Stock Price PerformanceIs a Turnaround Possible for the FEMSA Stock?Although FEMSA’s Health division looks far from witnessing a recovery in the near-term, the company’s progress with its FEMSA Forward Strategy, launched in February 2023, bodes well. The plan focuses on creating long-term value in its core businesses: retail (including the Health Division), Coca-Cola FEMSA, and [email protected] strategy also includes exploring alternatives for its strategic businesses, including potential divestments. As part of this initiative, the Zacks Rank #3 (Hold) company sold 13.9% of its outstanding shares in Heineken in 2023, reducing its stake to less than 1%. The company also plans to divest its interests in Solística and other non-core businesses by April 2025, reducing its imp...

View stock analysis, news, and events for Fomento Economico Mexicano Sab De Cv Units Cons. Of 5 Shsb